Article detail · 2013
Development and Evaluation of Paclitaxel Nanoparticles Using a Quality-by-Design Approach
YÖKSİS
OpenAlex
SJR Q1
JCR Q2
Citations 96
Top 10%
Percentile 90.1%
FWCI 2.73
- Year
- 2013
- Type
- article
Data source split
- YÖKSİS YÖKSİS article record
- YÖKSİS venue Journal of Pharmaceutical Sciences
- Catalog match (ISSN) Journal of Pharmaceutical Sciences
- OpenAlex OpenAlex enrichment (abstract, citations, topics)
Abstract
Abstract not compiled yet; it will appear after the DergiPark / OpenAlex queue runs.
Topics
Citations
OpenAlex cited_by_count. Not a WoS or Scopus citation count; those sources have no separate column here.
96 citations
OpenAlex cited_by_count (cache / database)
17 publications in the local catalog that cite this work (OpenAlex reference match; not the full global list).
- Quality by design case study 1: Design of 5-fluorouracil loaded lipid nanoparticles by the W/O/W double emulsion solvent evaporation method 2016
- Quality by design case study 1 Design of 5 fluorouracil loaded lipid nanoparticles by the W O W double emulsion Solvent evaporation method 2016
- GEMCITABINE HYDROCHLORIDE-LOADED LIPOSOMES AND NANOPARTICLES: COMPARISON OF ENCAPSULATION EFFICIENCY, DRUG RELEASE, PARTICLE SIZE, AND CYTOTOXICITY 2018
- Combination of Paclitaxel and R-flurbiprofen loaded PLGA nanoparticles suppresses glioblastoma growth on systemic administration 2020
- Combination of Paclitaxel and R-flurbiprofen loaded PLGA nanoparticles suppresses glioblastoma growth on systemic administration 2020
- Combination of Paclitaxel and R-flurbiprofen loaded PLGA nanoparticles suppresses glioblastoma growth on systemic administration 2020
- Combination drug delivery with actively-targeted PLGA nanoparticles to overcome multidrug resistance in breast cancer 2019
- Design, characterization and evaluation of cucurbitacin B-loaded core\u2013shell-type hybrid nano-sized particles using DoE approach 2021
- Design, characterization and evaluation of cucurbitacin B-loaded core\u2013shell-type hybrid nano-sized particles using DoE approach 2021
- Applying Quality by Design Principles in the Development and Preparation of a New Radiopharmaceutical: Technetium-99m-Imatinib Mesylate 2020